<TABLE> <S> <C>

<ARTICLE>                                            6
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM MAXXIM
MEDICAL'S FORM 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER>                    1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              OCT-29-2000
<PERIOD-START>                                 NOV-01-1999
<PERIOD-END>                                   JUL-30-2000
<INVESTMENTS-AT-COST>                          37,526
<INVESTMENTS-AT-VALUE>                         37,526
<RECEIVABLES>                                  69,502
<ASSETS-OTHER>                                 37,363
<OTHER-ITEMS-ASSETS>                          368,565
<TOTAL-ASSETS>                                512,956
<PAYABLE-FOR-SECURITIES>                            0
<SENIOR-LONG-TERM-DEBT>                       431,769
<OTHER-ITEMS-LIABILITIES>                      36,188
<TOTAL-LIABILITIES>                           494,957
<SENIOR-EQUITY>                                     0
<PAID-IN-CAPITAL-COMMON>                       (9,696)
<SHARES-COMMON-STOCK>                       5,601,085
<SHARES-COMMON-PRIOR>                      14,278,942
<ACCUMULATED-NII-CURRENT>                     (45,403)
<OVERDISTRIBUTION-NII>                              0
<ACCUMULATED-NET-GAINS>                             0
<OVERDISTRIBUTION-GAINS>                            0
<ACCUM-APPREC-OR-DEPREC>                            0
<NET-ASSETS>                                   13,589
<DIVIDEND-INCOME>                                   0
<INTEREST-INCOME>                                   0
<OTHER-INCOME>                                 (2,063)
<EXPENSES-NET>                                      0
<NET-INVESTMENT-INCOME>                             0
<REALIZED-GAINS-CURRENT>                            0
<APPREC-INCREASE-CURRENT>                           0
<NET-CHANGE-FROM-OPS>                               0
<EQUALIZATION>                                      0
<DISTRIBUTIONS-OF-INCOME>                           0
<DISTRIBUTIONS-OF-GAINS>                            0
<DISTRIBUTIONS-OTHER>                               0
<NUMBER-OF-SHARES-SOLD>                             0
<NUMBER-OF-SHARES-REDEEMED>                         0
<SHARES-REINVESTED>                                 0
<NET-CHANGE-IN-ASSETS>                       (271,609)
<ACCUMULATED-NII-PRIOR>                             0
<ACCUMULATED-GAINS-PRIOR>                           0
<OVERDISTRIB-NII-PRIOR>                             0
<OVERDIST-NET-GAINS-PRIOR>                          0
<GROSS-ADVISORY-FEES>                               0
<INTEREST-EXPENSE>                             35,823
<GROSS-EXPENSE>                               371,609
<AVERAGE-NET-ASSETS>                                0
<PER-SHARE-NAV-BEGIN>                               0
<PER-SHARE-NII>                                     0
<PER-SHARE-GAIN-APPREC>                             0
<PER-SHARE-DIVIDEND>                                0
<PER-SHARE-DISTRIBUTIONS>                           0
<RETURNS-OF-CAPITAL>                                0
<PER-SHARE-NAV-END>                                 0
<EXPENSE-RATIO>                                     0


</TABLE>